About dunbar pharmaceuticals
Founded in 2021 and headquartered in Athlone, Ireland, Dunbar Pharmaceuticals is a research-driven pharmaceutical company specialising in the development and GMP production of plant-derived cannabinoid Active Pharmaceutical Ingredients (APIs).
Our mission is to expand global access to natural, effective therapies by delivering pharmaceutical-grade cannabinoid innovations that meet the highest standards of safety, quality, and GMP compliance.
Advancing Cannabinoid Science with Precision and Purpose
EU cGMP Certified
Founded in 2021, Dunbar Pharma is a Irish GMP manufacturer specialising in pharmaceutical-grade cannabinoid Active Pharmaceutical Ingredients (APIs) and other highly controlled plant-based cGMP materials for the global cannabinoid and specialty pharmaceutical sectors.
Our state-of-the-art, EU cGMP-certified and inspected facility is dedicated to the research, development, and commercial production of APIs and complex cGMP products that are difficult to source reliably, serving niche, highly regulated markets worldwide.
High Quality Cannabinoid APIs
We focus on bringing the highest quality cannabinoid APIs to market, underpinned by rigorous GMP processes, scientific integrity, and a commitment to advancing patient care.
We combine world-class, in-house research, manufacturing, stability testing, and comprehensive quality control to deliver APIs that meet the most demanding pharmaceutical standards.
Our Expertise
At Dunbar, we excel in the research, development, and manufacturing of plant-based cannabinoid APIs.
Our proprietary production methods enable us to produce Dronabinol API exclusively from cannabis plant material, ensuring a natural and sustainable product. Our state-of-the-art facility in the Irish Midlands is equipped with an in-house Quality Control laboratory featuring advanced analytical capabilities such as High-Performance Liquid Chromatography (HPLC) and Gas Chromatography-Mass Spectrometry (GC-MS), we ensure rigorous quality control and product consistency.
Our Vision
To be the global leader in cannabinoid API manufacturing, recognised for scientific excellence, regulatory compliance, and an unwavering commitment to improving patient outcomes.
Our Mission
To advance cannabinoid therapeutics through the development and manufacture of pharmaceutical-grade APIs, backed by cutting-edge research, rigorous quality control, and a patient-first approach.
Get In Touch With Us
Have a question or partnership inquiry? Contact our team, we’re here to help.